Onterris, Inc.
Business
Montrose Environmental Group, Inc. provides environmental services to help clients and communities meet environmental goals and manage complex regulatory, operational and emergency needs. It offers scientific advisory and consulting, environmental emergency response, permitting, laboratory testing and analysis for air, water and soil, and remediation and reuse engineering and treatment technologies. Operations are organized into three segments: Assessment, Permitting and Response; Measurement and Analysis; and Remediation and Reuse, delivering consulting, testing, laboratory analysis, design and project implementation. Montrose serves private and public sector clients across the United States, Canada, Australia and Europe through direct project engagements, contracts and a national laboratory and field services network.
Summary from filing dated 2025-03-03
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenues | 831 | 696 | 624 | 544 | 546 | |
| Cost of revenues (exclusive of depreciation and amortization shown below) | 496 | 418 | 384 | 352 | 369 | |
| Selling, general and administrative expense | 271 | 262 | 223 | 176 | 118 | |
| Fair value changes in business acquisition contingencies | 900,000 | 534,000 | 84,000 | −3 | 24 | |
| Depreciation and amortization | 51 | 53 | 46 | 47 | 45 | |
| Income (loss) from operations | 12 | −37 | −28 | −28 | −9 | |
| Other income (expense), net | 19 | −2 | 4 | 4 | −3 | |
| Interest expense, net | −20 | −16 | −8 | −5 | −12 | |
| Total other expense, net | −504,000 | −18 | −3 | −2 | −14 | |
| Income (loss) before expense from income taxes | 11 | −54 | −32 | −30 | −24 | |
| Income tax expense (benefit) | 12 | 8 | −980,000 | 2 | 2 | |
| Net loss | −843,000 | −62 | −31 | −32 | −25 | |
| Equity adjustment from foreign currency translation | −1 | −2 | −231,000 | −28,000 | −35,000 | |
| Comprehensive income (loss) | −2 | −64 | −31 | −32 | −25 | |
| Weighted average common shares outstanding - basic | 35 | 33 | 30 | 30 | 27 | |
| Weighted average common shares outstanding - diluted | 35 | 33 | 30 | 30 | 27 | |
| Net income (loss) per share attributable to common stockholders - basic | −0.14 | −2.22 | −1.57 | −1.62 | −1.56 | |
| Net income (loss) per share attributable to common stockholders - diluted | −0.14 | −2.22 | −1.57 | −1.62 | −1.56 | |
| Convertible and redeemable Series A-2 Preferred Stock dividend | −4 | −11 | −16 | −16 | −16 | |
| Net income (loss) attributable to common stockholders | −5 | −73 | −47 | −48 | −42 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash, cash equivalents and restricted cash | 11 | 13 | 23 | 90 | 146 | |
| Accounts receivable, net | 155 | 159 | 112 | 95 | 99 | |
| Contract assets | 59 | 52 | 52 | 52 | 40 | |
| Prepaid and other current assets | 15 | 14 | 14 | 10 | 8 | |
| Total current assets | 240 | 238 | 201 | 248 | 294 | |
| Property and equipment, net | 64 | 64 | 57 | 36 | 32 | |
| Operating lease right-of-use asset, net | 37 | 40 | 32 | 26 | 24 | |
| Finance lease right-of-use asset, net | 38 | 20 | 13 | 10 | 9 | |
| Goodwill | 467 | 468 | 364 | 324 | 312 | |
| Other intangible assets, net | 126 | 153 | 141 | 142 | 161 | |
| Other assets | 10 | 9 | 8 | 6 | 2 | |
| Total assets | 981 | 990 | 817 | 792 | 833 | |
| Accounts payable and other accrued liabilities | 72 | 64 | 60 | 63 | 69 | |
| Accrued payroll and benefits | 53 | 34 | 35 | 21 | 26 | |
| Business acquisitions contingent consideration, current | 15 | 27 | 4 | 4 | 31 | |
| Current portion of operating lease liabilities | 11 | 11 | 10 | 8 | 7 | |
| Current portion of finance lease liabilities | 7 | 5 | 4 | 4 | 4 | |
| Current portion of long-term debt | 11 | 18 | 14 | 12 | 11 | |
| Total current liabilities | 168 | 159 | 126 | 111 | 148 | |
| Business acquisitions contingent consideration, long-term | 3 | 6 | 2 | 4 | 4 | |
| Other non-current liabilities | 7 | 6 | 7 | 13,000 | 100,000 | |
| Deferred tax liabilities, net | 22 | 13 | 6 | 6 | 4 | |
| Operating lease liability, net of current portion | 28 | 31 | 25 | 19 | 17 | |
| Finance lease liability, net of current portion | 25 | 11 | 8 | 6 | 6 | |
| Long-term debt, net of deferred financing fees | 277 | 205 | 149 | 152 | 162 | |
| Total liabilities | 530 | 451 | 343 | 326 | 364 | |
| Commitments and contingencies | — | — | — | — | — | |
| Additional paid-in-capital | 728 | 721 | 532 | 493 | 464 | |
| Accumulated deficit | −274 | −273 | −210 | −179 | −148 | |
| Accumulated other comprehensive loss | −3 | −2 | −223,000 | 8,000 | 36,000 | |
| Total stockholders equity | 451 | 446 | 321 | 313 | 317 | |
| Total liabilities, convertible and redeemable Series A-2 Preferred Stock and Stockholders' Equity | 981 | 990 | 817 | 792 | 833 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net loss | −843,000 | −62 | −31 | −32 | −25 | |
| Provision (recovery) for credit loss | 7 | −146,000 | 3 | — | — | |
| Non-cash leases expense | 12 | 12 | 10 | — | — | |
| Stock-based compensation expense | 43 | 65 | 47 | 43 | 10 | |
| Fair value changes in financial instruments | −18 | 3 | −4 | −3 | 2 | |
| Write off of deferred financing costs | 913,000 | — | — | — | — | |
| Deferred income taxes | 10 | 4 | −980,000 | 2 | 2 | |
| Other operating activities, net | 668,000 | 754,000 | 3 | −4 | — | |
| Accounts receivable and contract assets | −10 | −42 | −3 | 4 | −36 | |
| Prepaid expenses and other current assets | −3 | −930,000 | −918,000 | −2 | −1 | |
| Accounts payable and other accrued liabilities | 8 | 4 | −9 | −10 | 24 | |
| Accrued payroll and benefits | 19 | −2 | 9 | −7 | 3 | |
| Payment of contingent consideration | — | — | −611,000 | −19 | −16 | |
| Change in operating leases | −12 | −12 | −10 | −9 | −8 | |
| Other assets | 1 | 378,000 | — | — | — | |
| Net cash provided by operating activities | 107 | 22 | 56 | 21 | 38 | |
| Purchases of property and equipment | −16 | −21 | −30 | −10 | −7 | |
| Proceeds from the sale of property and equipment | 712,000 | 2 | 2 | 174,000 | 597,000 | |
| Proprietary software development and other software costs | −695,000 | −3 | −3 | −593,000 | −699,000 | |
| Purchase price true ups | 458,000 | −3 | −1 | −389,000 | −9 | |
| Minority investments | — | −210,000 | −3 | — | — | |
| Cash paid for acquisitions, net of cash acquired | — | −113 | −66 | −29 | −56 | |
| Net cash used in investing activities | −16 | −138 | −102 | −39 | −72 | |
| Proceeds from revolving line of credit | 478 | 403 | — | — | 109 | |
| Repayment of the revolving line of credit | −420 | −378 | — | — | −109 | |
| Proceeds from the aircraft loan | — | — | 11 | — | — | |
| Repayment of aircraft loan | −1 | −1 | −591,000 | — | — | |
| Proceeds from term loan | 200 | 50 | — | — | 175 | |
| Repayment of term loan | −192 | −15 | −12 | −9 | −174 | |
| Payment of contingent consideration and other purchase price true ups | −11 | −363,000 | −2 | −11 | −10 | |
| Repayment of finance leases | −11 | −5 | −5 | −4 | −3 | |
| Payments of deferred financing costs | −2 | −348,000 | — | −183,000 | −446,000 | |
| Proceeds from issuance of common stock for exercised stock options | 1 | 2 | 5 | 2 | 7 | |
| Proceeds from issuance of common stock in follow-on offering, net of issuance costs | — | 122 | — | — | — | |
| Taxes paid related to net share settlement of equity awards | −11 | — | — | — | — | |
| Proceeds from building sale leaseback | 3 | — | — | — | — | |
| Dividend payment to the series A-2 stockholders | −4 | −11 | −16 | −16 | −16 | |
| Redemption of series A-2 Preferred Stock | −122 | −60 | — | — | — | |
| Net cash provided by (used in) financing activities | −93 | 106 | −20 | −39 | 146 | |
| Change in cash, cash equivalents and restricted cash | −1 | −10 | −66 | −57 | 112 | |
| Foreign exchange impact on cash balance | −224,000 | −497,000 | −876,000 | −111,000 | −183,000 | |
| Cash paid for interest | 18 | 15 | 8 | 7 | 5 | |
| Cash paid for income tax | 6 | 4 | 997,000 | 789,000 | 412,000 | |
| Property and equipment purchased under finance leases | 23 | 9 | 8 | 5 | 2 | |
| Acquisitions unpaid contingent consideration | 18 | 33 | 6 | 8 | 36 | |
| Acquisitions contingent consideration paid in common stock | 7 | 1 | 1 | — | 26 | |
| Non-cash considerations received from sale of subsidiary | 4 | — | — | — | — | |
| Accrued purchases of property and equipment | 1 | 983,000 | 1 | 2 | 790,000 | |
| Common stock issued to acquire new businesses | — | 11 | 3 | — | 8 | |
| Accrued lease surrender liability | — | — | 6 | — | — | |
| Promissory note receivable issued in connection with the sale of assets of the Discontinued Specialty Lab | — | — | 4 | — | — |